The AI-enabled drug discovery market is projected to grow from USD 8,176.5 million in 2026 to USD 33,951.6 million by 2036, at a CAGR of 15.3%. AI target identification platforms will dominate with a 41.0% market share, while small-molecule drug discovery will lead the applications segment with a 46.0% share.